PerSurge (NOA-30) phase II trial of perampanel treatment around surgery in patients with progressive glioblastoma

Glioblastoma is the most frequent and a particularly malignant primary brain tumor with no efficacy-proven standard therapy for recurrence. It has recently been discovered that excitatory synapses of the AMPA-receptor subtype form between non-malignant brain neurons and tumor cells.